Evidence map›Paper›PMID 28524081›Full record

ArticleMolecules (Basel, Switzerland)2017

Protective Effects of Tormentic Acid, a Major Component of Suspension Cultures of Eriobotrya japonica Cells, on Acetaminophen-Induced Hepatotoxicity in Mice.

Wen-Ping Jiang, Shyh-Shyun Huang, Yoshikazu Matsuda, Hiroshi Saito, Naoto Uramaru, Hui-Ya Ho, Jin-Bin Wu, Guan-Jhong Huang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Antioxidants (Basel, Switzerland) · 2021
    Article
  11. Review
  12. Article
  13. The Protective Effect ofEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Hepatoprotective Effect of Ugonin M, AMolecules (Basel, Switzerland) · 2018
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Wen-Ping JiangSchool of Pharmacy, China Medical University, No. 91, Hsueh-Shih R., Taichung 40402, Taiwan. u101053651@cmu.edu.tw.
Shyh-Shyun HuangSchool of Pharmacy, China Medical University, No. 91, Hsueh-Shih R., Taichung 40402, Taiwan. sshuang@mail.cmu.edu.tw.
Yoshikazu MatsudaNihon Pharmaceutical University, 10281, Komuro, Ina-machi, Kitaadachi-gun, Saitama 3620806, Japan. yomatsuda@nichiyaku.ac.jp.
Hiroshi SaitoNihon Pharmaceutical University, 10281, Komuro, Ina-machi, Kitaadachi-gun, Saitama 3620806, Japan. hiroshis@nichiyaku.ac.jp.
Naoto UramaruNihon Pharmaceutical University, 10281, Komuro, Ina-machi, Kitaadachi-gun, Saitama 3620806, Japan. uramaru@nichiyaku.ac.jp.
Hui-Ya HoJen Li Biotech Company Ltd., Taiping District, Taichung 41143, Taiwan. jlbioaya@gmail.com.
Jin-Bin WuSchool of Pharmacy, China Medical University, No. 91, Hsueh-Shih R., Taichung 40402, Taiwan. jbwu@mail.cmu.edu.tw.
Guan-Jhong HuangDepartment of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan. gjhuang@mail.cmu.edu.tw.
China Medical University · TWNihon Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An acetaminophen (APAP) overdose can cause hepatotoxicity and lead to fatal liver damage. The hepatoprotective effects of tormentic acid (TA) on acetaminophen (APAP)-induced liver damage were investigated in mice. TA was intraperitoneally (i.p.) administered for six days prior to APAP administration. Pretreatment with TA prevented the elevation of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (T-Bil), total cholesterol (TC), triacylglycerol (TG), and liver lipid peroxide levels in APAP-treated mice and markedly reduced APAP-induced histological alterations in liver tissues. Additionally, TA attenuated the APAP-induced production of nitric oxide (NO), reactive oxygen species (ROS), tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), and IL-6. Furthermore, the Western blot analysis showed that TA blocked the protein expression of inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2), as well as the inhibition of nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinases (MAPKs) activation in APAP-injured liver tissues. TA also retained the superoxidase dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT) in the liver. These results suggest that the hepatoprotective effects of TA may be related to its anti-inflammatory effect by decreasing thiobarbituric acid reactive substances (TBARS), iNOS, COX-2, TNF-α, IL-1β, and IL-6, and inhibiting NF-κB and MAPK activation. Antioxidative properties were also observed, as shown by heme oxygenase-1 (HO-1) induction in the liver, and decreases in lipid peroxides and ROS. Therefore, TA may be a potential therapeutic candidate for the prevention of APAP-induced liver injury by inhibiting oxidative stress and inflammation.

Indexed as

AcetaminophenAlanine TransaminaseAnimalsAspartate AminotransferasesBilirubinCatalaseCells, CulturedChemical and Drug Induced Liver InjuryCholesterolCyclooxygenase 2EriobotryaGlutathione PeroxidaseInjections, IntraperitonealInterleukin-1betaInterleukin-6LiverAcetaminophenAlanine TransaminaseAspartate AminotransferasesBilirubinCatalaseCholesterolCyclooxygenase 2euscaphic acidGlutathione PeroxidaseIL1B protein, mouseInterleukin-1betaInterleukin-6interleukin-6, mouseNitric OxideNitric Oxide Synthase Type IINos2 protein, mouseProtective AgentsPtgs2 protein, mouseReactive Oxygen SpeciesSuperoxide DismutaseTriglyceridesTriterpenesTumor Necrosis Factor-alphaacetaminophenanti-inflammationantioxidationhepatoprotectiveHO-1 (heme oxygenase-1)mapkNF-κBreactive oxygen species.tormentic acid

Identifiers

PMID28524081
PMCPMC6154347
OpenAlexW2615368939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.